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A R T I C L E   I N F O A B S T R A C T 
Non-adherence to medication is often an unrecognized risk factor that contributes 
to failure of the therapeutic plan. The purpose of the study was to identify factors 
related to high, medium and low medication adherence among adult Saudi 
patients with hypertension and diabetes mellitus. This study is designed as a 
descriptive cross sectional survey and was conducted in three tertiary care 
hospitals of Al-Qassim province of Saudi Arabia. The data was collected using the 
8-item Morisky Medication Adherence Scale (MMAS-8) and analyzed by SPSS. 
Three levels of adherence were considered based on the following scores: 0 to <6 
(low); 6 to <8 (medium); 8 (high). Of the 396 patients interviewed, 52% reported 
low adherence to prescribed medication. Multinomial logistic regression analysis 
was conducted. Gender, age, literacy level, duration of illness and type of chronic 
disease were negatively associated with medication adherence. The study shows 
very high proportion of low and medium adherence on long term medication, 
which may be responsible for the failure of achieving therapeutic outcome. Further 
investigation is required to evaluate the applicability of MMAS-8 as a tool of 
measuring medication adherence among Saudi patients with chronic diseases. 
Adherence enhancing strategies should also be evaluated in separate patients 
group.  
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INTRODUCTION 
Medication nonadherence is a multidimensional 
health care problem and is frequently the principal 
obstacle to successful pharmacotherapy in 
ambulatory patients (Vrijens et al. 2012). Poor 
adherence with rationally prescribed medication 
undermines benefits of treatment and is also 
associated with adverse events, increased cost, 
higher morbidity and mortality among the patients 
(Ulrich-Laufs 2010). Adherence to medication in 
chronic diseases such as hypertension and diabetes 
mellitus acts as an essential part of successful 
therapeutic outcome (Insel 2006). Factors 
contributing to nonadherence of medication include 
number of chronic conditions, dosing frequency or 
presence of side effects, personal beliefs and health 
literacy, patient’s relationship with healthcare 
providers, age and cost of medication (Paraskevi 
2012). 
 
Diabetes mellitus and high blood pressure are among 
the leading healthcare issues that affect a growing 
number of people in Saudi Arabia according to the 
survey by the Kingdom of Saudi Arabia and the 
Institute for Health Metrics and Evaluation (IHME) 
at the University of Washington. The survey further 
states that the total prevalence of diabetes in Saudi 
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Arabia was 14.8 % for males and 11.7% for females 
and hypertension was 17.7% for males and 12.5 % for 
females in 2013. According to the survey, conducted 
in 2013, 1 million of Saudi males and females are on 
diabetic medication and 0.6 million are on 
hypertensive medication (Mokdad 2016). 
 
A medication adherence study conducted in Riyadh, 
Saudi Arabia found that 40% of the local patients on 
prescribed medication with multiple chronic diseases 
and high illiteracy rate had low adherence 
(Tourkmani 2012). Main reasons of non-adherence 
among Saudi patients were found to be forgetfulness, 
fear of side effects and lack of health education 
(Khan et al. 2012). The findings of the current study 
could provide more comprehensive information for 
physicians and pharmacists in Saudi Arabia with 
targets to investigate the ways to enhance medication 
adherence especially in patients with chronic 
diseases on long term medication to achieve 
therapeutic outcome. 
MATERIALS AND METHODS 
This study is a descriptive cross sectional interviewer 
assisted survey and was conducted on patients with 
either hypertension, diabetes or both visiting main 
tertiary care hospitals of Al-Qassim province of 
Saudi Arabia namely King Fahad specialist hospital, 
central hospital Buraidah and King Saud hospital 
between September 2013 and September 2014. The 
selected hospitals are main public tertiary care 
hospitals and cater to 80% of the diabetes and 
hypertensive patients in the region. These hospitals 
have outpatient clinics run by professionally trained 
family physicians. Most of the Pharm. D. internship 
students of Qassim University perform their 
internship in these hospitals.   
 
The study population consists of registered adult 
hypertensive and/or diabetic Saudi patients in the 
outpatient clinics of the hospitals that have been 
prescribed diabetic and/or hypertensive medication 
for more than 6 months and not known to have 
cognitive impairment or psychiatric illness. Patients 
meeting the above inclusion criteria were 
approached and consent was taken to participate in 
the study. Pharm. D. internship students from 
Qassim University (supporting staff) conducted the 
interview and explained the study program to each 
patient. The interview was conducted during 
patient’s follow-up and medication refills during the 
clinic hours (8 am to 2 pm weekdays) at outpatient 
clinic and out-patient pharmacy. Patients were 
selected using random time intervals on each day of 
the study period and to avoid any duplication we 
started first six months at out-patient pharmacy 
where patient came to refill their diabetic and 
hypertensive medications then at out-patient clinics 
outside the physician's office for remaining six 
months. Data were collected every end of the week. 
About 500 patients were approached to take part in 
the study, in which 425 patients consented to 
participate. They were interviewed to collect the 
demographic data and medical history. It took an 
average of 5 minutes to complete an interview. 
Literate patients (having secondary or higher 
education) were given the English version of the 
questionnaire, whereas illiterate patients or those 
with lower level of literacy, were interviewed by the 
supporting staff (all native Arabic speakers) using 
the same questionnaire and their answers were 
recorded. Supporting staff were advised and given 
training to avoid any prejudice and potential social 
desirability bias (Alhewiti 2014). Patients with 
inability to understand spoken words, such as those 
with visual or hearing impairment, were excluded 
from the study. 
 
The supporting staff who have conducted all the 
interviews attended a standardized workshop on 
study protocol and questionnaire administration 
before the start of the study and took part in the 
focus group discussion to determine the reliability 
and suitability of the questionnaire. Permission was 
taken from Professor Donald E. Morisky to use 
MMAS-8 Scale. The research protocol was evaluated 
and permission was granted from the ethical 
committee of the College of Pharmacy, Qassim 
University. 
 
Medication Adherence Measure 
The questionnaire was divided into three sections. 
The first section contains demographic characteristic 
of patients like age, gender, education level, and type 
and duration of diagnosed chronic disease. The 
second section included patient adherence towards 
medication and was measured using eight item 
Morisky Medication Adherence Scale (MMAS-8). The 
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first seven items in the MMAS-8 have dichotomous 
responses (yes/no) and they are formulated in a way 
to avoid acquiescence bias, whereas the eighth item 
has a 5 point likert scale response (Morisky et al. 
2008). Three levels of adherence were considered 
based on the following scores: 0 to <6 (low); 6 to <8 
(medium); 8 (high). MMAS-8 is designed to reverse 
the code response in a positive direction for item 
number 5 and standardize the code for item 8 (0-4), 
resulting in a scale from low adherence to high 
adherence.  Item 8 is divided by 4 when calculating a 
summated score. This procedure standardizes the 5-
point likert scale.  The total scale has a range of 0 to 
8.0. The eight-item compliance scale had an alpha 
reliability of 0.83 (n= 1367) among patients 
diagnosed with essential hypertension attending an 
outpatient clinic of a large teaching hospital 




Based on previous medication adherence studies 
performed in Saudi Arabia (Tourkmani 2012; Khan et 
al. 2012; Alhewiti 2014), and after using NCSS-PASS 
(Power Analyses and Sample Size) 11 V11.0.7 
program with desired 95% confidence interval of ±5, 
the estimated sample size was 425.   
 
The PASW (Predictive Analytic Software) V18 (SPSS) 
was used for all data analysis. Chi-square tests and 
Student’s t-tests were used for categorical and 
continuous variables, respectively. Association 
between adherence and continuous variables were 
evaluated using multinomial logistic regression 
model for adjustment. All the data entered into the 
software were double checked for their accuracy of 
the survey responses. All p values ≤0.05 were 
regarded as statistically significant. 
RESULTS AND DISCUSSION 
A total of 425 patients were screened during the 
study period. Of them, 396 patients were included 
and surveyed in the final analysis and remaining 29 
patients were excluded from the study due to 
incomplete questionnaires. We have used 75% 
completion criterion for establishing eligibility. The 
median value of all non-missing items would be 
substituted for the missing item for individuals 
meeting the eligibility criterion i.e. if 1 or 2 items are 
missing, the median values of the other 7 or 8 items 
were substituted for the missing item. 
 
Among 396 patient, 53.5% (n=212) were females and 
46.5% (n=184) were males. Socio-demographic 
characteristics of the patients are shown in Table 1. 
Almost two third of patients (67.4%) were more than 
45 years old. Of the statistics, majority of the patients 
(32.8%) have completed secondary education, while 
30% were illiterate.  
 
Overall 51.5% of the patients were found to have low 
adherence to prescribed medications (Table 1). When 
using multivariate logistic regression test, it was 
found that there was a negative association of age, 
gender, literacy level, duration and type of chronic 
disease with the adherence score (using MMAS-8). 
Chi-square was 8.610 with p value >0.05. The most 
common chronic disease among the patients was 
diabetes mellitus (42.2%) and most of them were 
found to have low adherence (53.9%) to prescribed 
medication. 
Patients with low adherence showed significantly 
higher level of forgetfulness in taking their 
medication (47.2%) followed by carelessness (40.7%). 
Participants with low and medium adherence had 
shown significant concern about their medication, in 
which 27.8% had stronger belief that medication is 
overused, harmful and addictive in nature. 
Participants reported adherence behaviour is shown 
in Table 2. 
The results of this study indicate major concern of 
nonadherence to medication among adult Saudi 
patients of diabetes mellitus and hypertension in Al-
Qassim region of Saudi Arabia.  
Prevalence of diabetes mellitus is estimated at 
approximately 24 percent in Saudi Adults which is 
three times higher than the global prevalence of 
diabetes mellitus (8.3%). Approximately 30 percent 
of Saudi adults are suffering from hypertension 
(Mokdad 2016). In the current study, we utilized 
MMAS-8 scale to assess poor medication adherence 
among diabetic and hypertensive patients of Al-
Qassim province of Saudi Arabia, after studying 
previous studies done in Saudi Arabia which 
reported high number of low adherence. Two 
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Studies conducted in Riyadh, Saudi Arabia found 
nonadherence to medication to be 56.9% and 40% 
(Alhewiti 2014; Tourkmani 2012). Overall prevalence 
of therapeutic nonadherence among diabetic patients 
in Al-Hasa district of Saudi Arabia was 67.9% (Khan, 
et al. 2012). In contrast to medication adherence rate 
of 51.5% in the current study, similar studies 
performed in neighbouring Gulf countries, such as 
UAE and Qatar showed nonadherence rates of 14% 
and 41.8% respectively (Arifulla et al. 2014; Jimmy et 
al. 2014). The high nonadherence rate to prescribed 
medication contributes to failure of therapeutic 
outcome, resulting in higher incidence of 
cardiovascular, cerebral and renal diseases (Insel  
2006), therefore the current study highlights the need 
for investigating adherence enhancing strategies to 
improve therapeutic outcome among the Saudi adult 
population with chronic diseases. 
Although statistics of the study showed that age, 
gender, literacy level, type and duration of illness is 
independent of medication nonadherence, slightly 
higher adherence was observed in older patients (>55 
years) compared to the young (age 26-35 years) 
(Table 1).  Illiterate patients were found to have 
higher adherence level as compared to highly 
educated patients, and this could be because patients 
with lower literacy levels were helped more by the 
interviewer in filling the questionnaire; another 
possible reason is that they may be less aware of the 
actual and potential side effects of medication than 
those with higher level of literacy (Alhewiti 2014).  
  
Table 1: Characteristics of study participants and their adherence levels. 
Characteristics 
 Number of Patients (%) 
  Total Low Medium High 
Total     n = 396 (100) n = 204 (51.5) n = 129 (32.6) n = 63 (15.9) 
Gender N (%), p >0.05 
        
 Male   184 (46.5) 96 (52.2) 56 (30.4) 32 (17.4) 
 Female   212 (53.5) 108 (50.9) 73 (34.4) 31 (14.6) 
Age (in years) N (%), p<0.05 
        
 18-25   22 (5.6) 12 (54.5) 6 (27.3) 4 (18.2) 
 26-35   30 (7.6) 21 (70.0) 7 (23.3) 1 (3.3) 
 36-45   77 (19.4) 35 (45.5) 30 (39.0) 12 (15.6) 
 46-55   140 (35.4) 76 (54.3) 46 (32.9) 18 (12.9) 
 > 55   127 (32) 60 (47.2) 40 (31.5) 27 (21.3) 
Literacy level N (%), p<0.05 
        
 Illiterate   117 (29.5) 52 (44.4) 43 (36.8) 22 (18.8) 
 Primary education  57 (14.5) 30 (52.6) 20 (35.1) 7 (12.3) 
 Secondary education   130 (32.8) 73 (56.2) 37 (28.5) 20 (15.3) 
 Higher education  92 (23.2) 49 (53.3) 29 (31.5) 14 (15.2) 
Duration of disease N (%), p>0.05 
      
 < 1 year 30 (7.6) 18 (60.0) 5 (16.7) 7 (23.3) 
 1-3 years 85 (21.5) 51 (60.0) 22 (25.9) 12 (14.1) 
 4-10 years 132 (33.3) 61 (46.2) 53 (40.2) 18 (13.6) 
 11-20 years 111 (28.0) 55 (49.5) 38 (34.2) 18 (16.2) 
 > 20 years 38 (9.6) 19 (50.0) 11 (28.9) 8 (21.1) 
Type of chronic disease N (%), p>0.05 
      
 Diabetes Mellitus (DM)  167 (42.2) 90 (53.9) 50 (39.9) 27 (16.2) 
 Hypertension (HT)  97 (24.5) 46 (47.4) 32 (33.0) 19 (19.6) 
 DM + HT     129 (32.6) 66 (51.2) 46 (35.7) 17 (13.2) 
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Table 2: Patient’s self-reported adherence behaviour as measured by MMAS-8* 
Questions 
Number of Patients (%) 
 ‘Yes’  ‘No’ 
Do you ever forget to take your medications? 187 (47.2) 209 (52.8) 
Are you careless at times about taking your medications? 161 (40.7) 235 (59.3) 
Do you stop taking your medications when you feel better? 101 (25.5) 295 (74.5) 
Do you stop taking your medications if they make you feel worse? 110 (27.8) 286 (72.2) 
Did you forget to take your medications yesterday? 96 (24.2)  300 (75.8) 
Over the past 2 weeks, were there any days you did not take your 
medications? 
91 (23.0) 305 (77) 
When you travel or leave the house, do you sometimes forget to take 
your medications? 
149 (37.6) 247 (62.4) 
How often do you have difficulty to remember taking all your 
medications? 
  
i. Never/rarely 128 (32.3) 
ii. Once in a while 127 (32.1) 
iii. Sometimes 110 (27.8) 
iv. Often 25 (6.3) 
v. Always 6 (1.5) 
*Morisky et al (2008), Morisky and DiMatteo (2011), Krousel-Wood et al (2009)
In this study, it was also found that the patients who 
are taking diabetes or hypertensive medications for 
the last 3 years or less were significantly less 
adherent to their prescribed medication than those 
who were on these medications for longer than 3 
years (Table 1). One of the key factors of adherence 
behaviour not covered in this study is 
polypharmacy, which is an important risk factor for 
medication interactions and adverse events and 
which could contribute towards lower and higher 
adherence levels of medication. Morisky Scale had 
demonstrated the ability to predict poor medication 
adherence, however one of its limitation is the lack of 
the threshold score or individual question that 
yielded high sensitivity and positive predictive 
values which necessitates the addition of more 
questions to improve the scale consistency and 
predictability (Tourkmani 2012). 
One of the main limitations of the current study is 
that patients, who are nonadherents to prescribed 
medication, may have been less likely to participate 
with the possibility of diluting the actual rates. We 
acknowledge that more questions about name of 
medication, dosage regimen, comorbidity and 
presence of complications could be added in the 
questionnaire, however these questions were omitted 
to avoid the lengthy questionnaire which could make 
the patient uncomfortable during interview. Another 
limitation of the study is exclusion of other races and 
ethnic populations in Saudi Arabia. Further studies 
are needed to better understand potential racial and 
ethnic disparities in adherence and ways to 
ameliorate them. Interviewer bias cannot be ruled 
out in our study but it is believed to have minimal 
impact on study validity (Alhewiti 2014).  
Further studies are needed to explore actual causes 
and potential factors associated with low level of 
medication adherence and patient’s belief towards 
medication in Saudi Arabia. 
CONCLUSIONS 
This study reported very high proportion of 
medication non-adherence among diabetic and 
hypertensive patients in Al-Qassim province of 
Saudi Arabia, which might result in patients not 
achieving desired therapeutic outcome. Further 
investigation is required to evaluate the applicability 
of MMAS-8 as a tool of measuring medication 
adherence among Saudi patients with chronic 
diseases. Moreover, adherence enhancing strategies 
should be evaluated in separate patients groups. 
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